CD38 and Ventricular arrhythmia: In addition, CD38 knockout, catalytically inactive CD38 and treatment with an antibody for CD38 (Ab68) in wild-type mice contributed to a decrease in basal heart rate, an increase in heart rate variability and altered calcium handling, protecting mice against developing catecholamine-induced ventricular arrhythmias [116].